CoChat

Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression

Trivedi, Madhukar H., Hollander, Eric, Nutt, David, Blier, Pierre · 2008 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

OBJECTIVE: Recent data indicate that more than 65% of patients with major depressive disorder (MDD) fail to achieve remission. This article reviews research on the current understanding and management of residual symptoms, i.e., subthreshold depressive symptoms present after recovery from a major depressive episode. DATA SOURCES: MEDLINE (1966 to June 2006) was searched using combinations of the following search terms: major depressive disorder, residual symptoms, remission, response, tachyphylaxis, antidepressant, algorithm, treatment, responsiveness, serotonin, norepinephrine, and dopamine. STUDY SELECTION: All relevant articles that were published in English and reported original study data related to residual symptoms in MDD were included. DATA EXTRACTION: Studies were examined for data related to the prevalence, presentation, consequences, treatment, and neurobiological underpinnings of residual symptoms associated with MDD. DATA SYNTHESIS: Residual symptoms are common among patients treated for MDD who do not achieve full remission. Incomplete remission is associated with increased risk of relapse, suicide, functional impairment, and higher use of health care resources. Several factors, including "downstream" neurochemical mechanisms and clinical factors such as lack of adherence, contribute to the high prevalence of residual symptoms. Various clinical strategies, including switching and substitution antidepressant therapies, are used to address unresolved depressive symptoms. Individual differences in therapeutic response contribute to inadequate treatment and are linked to numerous clinical and neurobiological factors, including noncompliance, underdosing, intolerance, disturbances in neural circuitry, and genetic variability in neurotransmitters. CONCLUSIONS: Future research is needed to more precisely characterize residual symptoms and their underlying biochemical and molecular mechanisms in order to develop more effective treatment methods.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v69n0211

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 153

Metadata

Authors
Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Bristol (GB)
  • University of Ottawa (CA)
Venue
The Journal of Clinical Psychiatry
Published
2008-02-15
Volume
69
Issue
2
Pages
246-258
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2041144155
Cited by
153
References
0
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 12 · 2012: 9
FWCI
10.28
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
residual depressive symptoms, major depressive disorder, incomplete remission, antidepressant response, antidepressant switching, tachyphylaxis, medication adherence, underdosing, relapse risk, suicide risk, functional disability, health care utilization, neurobiological mechanisms, serotonin, norepinephrine, dopamine, neural circuits
MeSH terms
Algorithms, Antidepressive Agents, Anxiety, Cognition Disorders, Decision Trees, Depression, Depressive Disorder, Dopamine, Humans, Hypothalamo-Hypophyseal System, Norepinephrine, Pituitary-Adrenal System, Serotonin, Sleep Wake Disorders, Neurotransmitter Uptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation, Adrenergic Uptake Inhibitors, Dopamine Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression. https://app.cochat.ai/papers/10.4088/jcp.v69n0211
The paper
Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P. (2008). Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v69n0211

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.